Based on much of the evidence for rapid ART, in March of 2021, the WHO recommended that ART should be started within two weeks of tuberculosis treatment at any CD4 count [35], especially for those with CD4 ≤ 50 cells/μL. This evidence concerns the gene CD4 and tuberculosis.